BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 8766524)

  • 1. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
    Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
    Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
    Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts.
    Ito A; Nakajima S; Sasaguri Y; Nagase H; Mori Y
    Br J Cancer; 1995 May; 71(5):1039-45. PubMed ID: 7734296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.
    Tamarina NA; McMillan WD; Shively VP; Pearce WH
    Surgery; 1997 Aug; 122(2):264-71; discussion 271-2. PubMed ID: 9288131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
    Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
    J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
    Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
    Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    Jones JL; Glynn P; Walker RA
    J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
    Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
    Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue.
    Kubota T; Nomura T; Takahashi T; Hara K
    Arch Oral Biol; 1996 Mar; 41(3):253-62. PubMed ID: 8735011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
    Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
    Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
    Kugler A; Hemmerlein B; Thelen P; Kallerhoff M; Radzun HJ; Ringert RH
    J Urol; 1998 Nov; 160(5):1914-8. PubMed ID: 9783985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.